1Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol, 1994,124:1.
2Vanx DL, Cory S,Adams JM. Bcl-2 gene promotes haemopoi-eric ceil survival and cooperates with c-myc to immortalize pre-B cells. Nautre, 1988,335 : 440.
3Upadhyay S, Li GY, Liu H, et al Bcl-2 suppresses expression of p21wAFtJCIP1 in breast epithelial cells. Cancer Res,1995,55:4520.
4Korsmeyer SJ, Shutter JR, Veis DJ, et al. Bel 2./bsx: a rheostat that regulates an anti-oxidant pathway and cell death.Semin Cancer Biol,1993,4:327.
5Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, 1995 ,80: 293.
6Korajewski S, Krajwaska M, Shabaik A, et al. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2.Am J Pathol,1994,145:1323.
7Gonzalez-Garcia M, Perez-Ballestro R, Ding L, et al. Bcl- x is the major mRNA from expressed during murine development and its product focalizes to the mitochondria, Development,1994,120:3033.
8Sato T, Hanada M, Bodrug S, et al. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acid Sci USA,1994,91:9238.
9Chittenden T, Harrington EA, O'Connor R. et al. Induction of apoptosis Ly the bcl- 2 homologue bak. Nature,1995,374:733.
10Yang E, Zha J, Joekel J, et al. Bad, a heterodimeric partner for bcl-xl and bcl-2, displaces bax and promoters cell death. Cell,1995,80:285.
4[4]Nahta R,Estera FJ.Bcl-2 antisense oligonucleotides:a potential novel strategy for the treatment of breast cancer[J].Semin Oncol,2003,30(5,Suppl 6):143-149.
5[5]Teieira C,Reed JC,Pratt MA.Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells[J].Cancer Res,1995,55:3 902-3 907.
6[6]Gao G,Dou DP.G(1) phase dependent expression of bcl-2 mRNA and protein correlate with chemresistance of human cancer cells[J].Mol Pharmacol,2000,58(5):1 001-1 010.
7[7]Del Bufalo D,Biroccio A,Trisciuoglio D,et al.Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used[J].Eur J Cancer,2002,38(18):2 455-2 462.
9[9]Tartora G,Caputo R,Damiano V,et al.Combined targeted inhibition of bcl-2,bcl-xl,epidermal growth factor receptor and protein kinase a type Ⅰ cause potent antitumor,apoptotic and antiangiogenci activity[J].Clin Cancer Res,2003,9(2):866-871.
10[10]Tanabe K,Kim R,Inoue H,et al.Antisense Bcl-2 and HER2 oligonucl-etide treatment of breast cancer cells enhance their sensitivity to anticancer drugs[J].Int J Oncol,2003,22(4):875-881.
